| scholarly article | Q13442814 |
| P50 | author | Catherine Verfaillie | Q615166 |
| Satish Khurana | Q56849614 | ||
| P2093 | author name string | Sarah Schouteden | |
| Chacko Joseph | |||
| Shannon M Buckley | |||
| Lia Margamuljana | |||
| P2860 | cites work | The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26 | Q24307887 |
| Structure and biology of tissue factor pathway inhibitor | Q28202845 | ||
| Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome | Q28291534 | ||
| glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development | Q28507693 | ||
| Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches | Q29617460 | ||
| Stem cells and niches: mechanisms that promote stem cell maintenance throughout life | Q29620450 | ||
| Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. | Q30486721 | ||
| Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes | Q32159654 | ||
| Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches. | Q33555818 | ||
| Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts | Q34123183 | ||
| Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist | Q34412254 | ||
| Annexin-2 is a regulator of stromal cell-derived factor-1/CXCL12 function in the hematopoietic stem cell endosteal niche | Q34516778 | ||
| Maintenance of HSC by Wnt5a secreting AGM-derived stromal cell line. | Q34543835 | ||
| Hematopoietic stem and progenitor cell trafficking | Q35256009 | ||
| The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. | Q36376700 | ||
| Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. | Q36401478 | ||
| Hematopoietic stem-cell transplantation | Q36461248 | ||
| A rapid single step staining technique for DNA analysis by flow microfluorimetry | Q36589209 | ||
| Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow | Q36735787 | ||
| Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine | Q36846935 | ||
| Mimicking stem cell niches to increase stem cell expansion | Q36979314 | ||
| Proteolytic processing of chemokines: implications in physiological and pathological conditions. | Q37075270 | ||
| Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis | Q37092134 | ||
| Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. | Q37400834 | ||
| Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling | Q40396816 | ||
| G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. | Q40724468 | ||
| Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. | Q40778640 | ||
| OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. | Q41120310 | ||
| Glypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor | Q41982133 | ||
| Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor | Q42836658 | ||
| Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV? | Q44846118 | ||
| Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors | Q45889148 | ||
| Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study | Q47945285 | ||
| Tissue factor pathway inhibitor: a possible mechanism of action. | Q52041324 | ||
| dally, a Drosophila glypican, controls cellular responses to the TGF-beta-related morphogen, Dpp. | Q52192046 | ||
| Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells | Q54745902 | ||
| Homing of fluorescently labeled murine hematopoietic stem cells | Q71103708 | ||
| Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group | Q73552614 | ||
| Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver | Q74541767 | ||
| Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 | Q77952550 | ||
| Modulation of hematopoietic stem cell homing and engraftment by CD26 | Q80450248 | ||
| CD26 inhibition on CD34+ or lineage- human umbilical cord blood donor hematopoietic stem cells/hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/Beta2null immunodeficient mice | Q80566195 | ||
| Engineering stem cell expansion | Q83392301 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2587-2595 | |
| P577 | publication date | 2013-01-17 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Glypican-3-mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance | |
| P478 | volume | 121 |
| Q38690194 | CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology |
| Q37268966 | Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor |
| Q38747421 | Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells. |
| Q37400143 | Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity |
| Q54114587 | Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development. |
| Q47846879 | Identification of a new adtrp1-tfpi regulatory axis for the specification of primitive myelopoiesis and definitive hematopoiesis |
| Q37006880 | Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types |
| Q42676530 | In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic |
| Q34471792 | Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioning |
| Q94544831 | Molecular Mechanism of Hippo-YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration |
| Q34454386 | SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors |
| Q47142453 | Stem cells in cancer therapy: opportunities and challenges |
| Q91721067 | Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets |
| Q26784454 | The Role of Dipeptidyl Peptidase - 4 Inhibitors in Diabetic Kidney Disease |
| Q34029715 | The nonglycemic actions of dipeptidyl peptidase-4 inhibitors |
| Q38099715 | The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation. |
| Q38387552 | Therapeutic potential of umbilical cord blood cells for type 1 diabetes mellitus. |
Search more.